Exploristics

For over ten years now, Exploristics has been providing a targeted statistical approach to fast track clinical development, increasing study success while reducing risks and costs. Given the impact of COVID-19 on clinical trials worldwide, salvaging disrupted trials and accelerating the development of treatments for unmet clinical need has never seemed more urgent. Many of Exploristics' clinical programme support solutions are built around the transformative KerusCloud study simulation platform; the statistical software is able to assess multiple aspects of clinical study design and analysis in parallel so studies can achieve statistically and clinically meaningful outcomes. Following the platform's success, Exploristics decided to build a new statistical software with additional functions and characteristics.